Accelerate Diagnostics Statistics
Total Valuation
AXDXQ has a market cap or net worth of 25. The enterprise value is 50.28 million.
| Market Cap | 25 |
| Enterprise Value | 50.28M |
Important Dates
The last earnings date was Thursday, September 18, 2025.
| Earnings Date | Sep 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXDXQ has 25.19 million shares outstanding. The number of shares has increased by 86.76% in one year.
| Current Share Class | 25.19M |
| Shares Outstanding | 25.19M |
| Shares Change (YoY) | +86.76% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 38.27% |
| Owned by Institutions (%) | 1.47% |
| Float | 15.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.00 |
| EV / Sales | 4.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.04 |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.70 |
| Interest Coverage | -2.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -73.66% |
| Return on Invested Capital (ROIC) | -147.78% |
| Return on Capital Employed (ROCE) | 1,334.97% |
| Revenue Per Employee | 109,327 |
| Profits Per Employee | -467,710 |
| Employee Count | 107 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.92 |
Taxes
| Income Tax | -66,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.23 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.87 |
| Relative Strength Index (RSI) | 32.35 |
| Average Volume (20 Days) | 100,209 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, AXDXQ had revenue of 11.70 million and -50.05 million in losses. Loss per share was -2.15.
| Revenue | 11.70M |
| Gross Profit | 2.70M |
| Operating Income | -35.31M |
| Pretax Income | -50.11M |
| Net Income | -50.05M |
| EBITDA | -31.89M |
| EBIT | -35.31M |
| Loss Per Share | -2.15 |
Balance Sheet
The company has 16.30 million in cash and 66.58 million in debt, giving a net cash position of -50.28 million or -2.00 per share.
| Cash & Cash Equivalents | 16.30M |
| Total Debt | 66.58M |
| Net Cash | -50.28M |
| Net Cash Per Share | -2.00 |
| Equity (Book Value) | -56.04M |
| Book Value Per Share | -2.22 |
| Working Capital | -8.96M |
Cash Flow
In the last 12 months, operating cash flow was -24.19 million and capital expenditures -509,000, giving a free cash flow of -24.70 million.
| Operating Cash Flow | -24.19M |
| Capital Expenditures | -509,000 |
| Free Cash Flow | -24.70M |
| FCF Per Share | -0.98 |
Margins
| Gross Margin | 23.12% |
| Operating Margin | -301.85% |
| Pretax Margin | -428.37% |
| Profit Margin | n/a |
| EBITDA Margin | -272.60% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AXDXQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -86.76% |
| Shareholder Yield | n/a |
| Earnings Yield | -200,180,000.00% |
| FCF Yield | -98,812,000.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
AXDXQ has an Altman Z-Score of -39.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.07 |
| Piotroski F-Score | 3 |